Our study further supports the significant associations of AGRN and ITGB2 with lung adenocarcinoma by integrating a longitudinal cohort study and large‐scale MR analysis, emphasising their potential as biomarkers for lung adenocarcinoma pathogenesis, and their value in clinical assessments and targeted therapies. The gene discussed is AGRN; the disease is lung adenocarcinoma.